Collagen dynamics in the breast cancer tumor microenvironment and therapeutic perspectives
Authors:
Open Access
- 29 November 2025
- journal article
- review article
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
Abstract
Breast Cancer (BC) remains one of the most prevalent malignancies among women globally, with its pathogenesis and clinical progression being profoundly regulated by the tumor microenvironment (TME). Collagen, the most abundant extracellular matrix (ECM) component, plays multifaceted roles in shaping the TME of BC. Aberrant cllagen deposition, crosslinking, and remodeling alter tissue stiffness and architecture, driving tumor initiation, growth, invasion, and metastasis through integrin and discoidin domain receptor-mediated mechanosignaling, growth factor regulation, and metabolic reprogramming. Collagen rich stroma also acts as a physical and biochemical barrier that restricts T cell infiltration, promotes macrophage polarization, and impairs natural killer cell (NK) cytotoxicity, thereby facilitating immune evasion and therapeutic resistance. Specific collagen isoforms, including types I, III, V, VI, X, and XI, exhibit context-dependent tumor promoting or tumor restraining effects, underscoring the complexity of roles. Recent advances in targeting collagen biology, such as enzymatic degradation, inhibition of crosslinking enzymes, blockade of collagen receptors, and immune modulation strategies demonstrates promising preclinical results, with several approaches progressing to clinical trials. Future perspectives emphasize the integration of collagen targeting therapies with immunotherapy and chemotherapy, alongside the development of predictive biomarkers to stratify patients most likely to benefit. Collectively, collagen represents both a critical regulator of BC pathogenesis and a promising therapeutic target with significant translational potential.Keywords
Funding Information
- The National Natural Science Foundation of China (82472842 and 82473350)
- Wuxi Double-Hundred Talent Fund Project (BJ2023075)
This publication has 172 references indexed in Scilit:
- Overcoming matrix barriers for enhanced immune infiltration using siRNA-coated metal-organic frameworksActa Biomaterialia, 2025
- EGCG‐enabled Deep Tumor Penetration of Phosphatase and Acidity Dual‐responsive Nanotherapeutics for Combinatory Therapy of Breast CancerSmall, 2024
- Is the voltage-gated sodium channel β3 subunit (SCN3B) a biomarker for glioma?Functional & Integrative Genomics, 2024
- Conserved immuno‐collagenic subtypes predict response to immune checkpoint blockadeCancer Communications, 2024
- Collagen Mineralization Decreases NK Cell‐Mediated Cytotoxicity of Breast Cancer Cells via Increased Glycocalyx ThicknessAdvanced Materials, 2024
- COL8A1 facilitates the growth of triple-negative breast cancer via FAK/Src activationBreast Cancer Research and Treatment, 2022
- Heterogeneous microenvironmental stiffness regulates pro-metastatic functions of breast cancer cellsActa Biomaterialia, 2021
- Identification of tumor‐associated macrophage subsets that are associated with breast cancer prognosisClinical and Translational Medicine, 2020
- Obesity‐Associated Adipose Stromal Cells Promote Breast Cancer Invasion through Direct Cell Contact and ECM RemodelingAdvanced Functional Materials, 2020
- Collagens—structure, function, and biosynthesisAdvanced Drug Delivery Reviews, 2003